$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Newcastle Disease Virus의 F와 HN 유전자 재조합 DNA 제조 및 면역원성

Construction of Recombinant DNA with F and HN Genes of Newcastle Disease Virus and Its Immunogenicity

Abstract

Recombinant DNA vaccines, based on plasmid vectors expressing an antigen under the control of a strong promotor, have several advantages over traditional vaccines. They have been shown to induce a full spectrum of immune responses for humoral and cellular systems and to secure the higher safety and the simplicity of administration. Thus, establishment of DNA vaccines against Newcastle disease virus (NDV) in poultry has been widely investigated using various virus strains and vector systems. In this study, the F and HN genes of NDV CBP-1 strains isolated from diseased pheasants and attenuated by serial passages in egg embryos were cloned using pSLIA vector and constructed two recombinants of pSLIA-tsF and pSLIA-tsHN. The recombinant plasmids were transfected into COS-7 cell and the expression of HN and F proteins were verified by immunofluorescence, SDS-PAGE and Western blot. The recombinant plasmids were injected intramuscularly and intradermally into C57B/6 mouse and a significant increment of HN and F antibodies was detected by ELISA. According to the results, it was implicative that the recombinant DNA could be utilized for development of recombinant DNA vaccine for NDV.

참고문헌 (35)

  1. Alexander DJ: Newcastle disease. Br Poult Sci 42: 5-22, 2001 
  2. Babiuk LA, van Drunen Littel-van den Hurk S, Babiuk SL: Immunization of animals: from DNA to the dinner plate. Vet Immunol Immunopathol 72: 189-202, 1999 
  3. Babiuk LA, Babiuk SL, Loehr BI, van Drunnen Littel-van den Hurk S: Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol 76: 1-23, 2000 
  4. Bos JD: The skin as an organ of immunity. Clin Exp Immunol 107: 3-5, 1997 
  5. Bruckner L, Stauber N, Brechtbuhl K, Hofmann MA: Detection of extraneous agents in vaccines using the polymerase chain reaction of Newcastle disease virus in poultry biologicals. Dev Biol Stand 86: 175-182, 1996 
  6. Chang KS, Kim JY, Kim S, Kim, TY, Song HJ, Jun MH: Expression of F protein gene of a thermostable isolate of Newcastle disease virus using Baculovirus expression system. Journal of Bacteriology and Virology 31(2): 163-174, 2001 
  7. Chang KS, Kwak KH, Jand SI, Kim JY, Kim TV, Song YD, Song HJ, Jun MH: Molecular cloning and nucleotide sequence of the gene encoding hemagglutinin-neuraminidase (HN) of Newcastle disease virus isolated from a diseased pheasant in Korea. Korean J Vet Serv 25: 245-257, 2002 
  8. Colman PM, Hoyne PA, Lawrence MC: Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol 67: 2972-2980, 1993 
  9. Dufour V: DNA vaccines: new applications for veterinary medicine. Vet Sci Tomorrow 1: 1-19, 2001 
  10. Fang WH, Liang XY: Expression of the Newcastle disease virus fusion glycoprotein in vero cells using attenuated Salmonella typhimurium as transgenic carrier. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34: 488-493, 2002 
  11. Fodor I, Horvath E, Fodor N, Nagy E, Rencendorsh A, Vakharia VN, Dube SK: Induction of protective immunity in chickens immunized with plasmid DNA encoding infectious bursal disease virus antigens. Acta Vet Hung 47: 481-492, 1999 
  12. Homhuan A, Prakongpan S, Poomvises P, Maas RA, Crommelin DJA, Kersten GFA, Jiskoot W: Virosome and ISCOM vaccines against Newcastle disease; preparation, characterization and immunogenicity. Eur J Phamacol Sci 22: 459-468, 2004 
  13. Kamiya N, Niitura M, Ono M, Kai C, Matsuura Y, Mikami T: Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells; the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res 32: 373-379, 1994 
  14. Karaca K, Sharma JM, Winslow BJ, Junker DE, Reddy S, Cochran M, McMillen J: Recombinant fowl pox viruses coexpressing chicken type I IFM and Newcastle disease virus HN and F genes; influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16 (16): 1496-1503, 1998 
  15. Kodihalli S, Haynes JR, Robinson HL, Webster RG: Crossprotection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J Viral 71: 3391-3396, 1997 
  16. Mayo MA: Virus Taxonomy-Houston 2002. Arch Virol 147: 5, 2002a 
  17. Mayo MA: A summary of taxonomic changes recently approved by ICTV. Arch Viral 147: 8, 2002b 
  18. Murakami Y, Kagino T, Niikura M, Mikami T, Ishii K, Matsuura Y: Characterization of Newcastle disease virus envelope glycoproteins expressed in insect cells. Virus Res 33: 123-137, 1994 
  19. Nagy E, Huber P, Krell PJ, Derbyshire JB: Synthesis of Newcastle disease virus-like envelopes in insect cells infected with a recombinant baculovirus expressing the hemagglutininneuraminidase of NDY. J Gen Virol 72: 753-756, 1991 
  20. Nishino Y, Niikura M, Suwa T, Onuma M, Gotoh B, Nagai Y, Mikami T: Analysis of the protective effect of the hemagglutinin-neuraminidase protein in Newcastle disease virus infection. J Gen Virol 71: 1187-1190, 1991 
  21. Oshop GL, Elankumaran S, Heckert RA: DNA vaccination in the avian. Vet Immunol Immunopathol 89: 1-12, 2002 
  22. Panda A, Elankumaran S, Krishnamurthy S, Huang Z, Samal SK: Loss of N-liked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus. J ViroI 78(10): 4965-4975, 2004 
  23. Reddy SK, Sharma JM, Ahmad J, Reddy DN, McMillen JK, Cook SM, Wild MA, Schwartz RD: Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogenfree chickens. Vaccine 14: 469-477, 1996 
  24. Robinson HL: Nucleic acid vaccines: an overview. Vaccine 15: 785-787, 1997 
  25. Sakaguchi M, Nakamura H, Sonoda K, Okamura H, Yokogawa K, Matsuo K, Hira K: Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type I. Vaccine 16(5): 472-479, 1998 
  26. Stauber N, Brechtbuhi K, Bruckner L, Hofmann MA: Detection of Newcastle disease virus in poultry vaccines using the polymerase chain reaction and direct sequencing of amplified cDNA. Vaccine 13: 360-364, 1995 
  27. Stone-Hulslander J, Morrison TG: Detection of an interaction between the HN and F proteins in Newcastle disease vius-infected cell. J ViroI 71(9): 6287-6295, 1997 
  28. Suarez DL, Schultz-Cherry S: The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis. 44: 861-868, 2000 
  29. Tan WS, Lau CH, Ng BK, Ibrahim AL, Yusoff K: Nucleotide sequence of the hemagglutinin-neuraminidase (RN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240. DNA Seq 6(1): 47-50, 1995 
  30. Taylor J, Edbauer C, Rey-senelonge A, Bouquet JF. Norton E, Goebel S, Desmettre P, Paoletti E: Newcastle disease virus fusion protein expressed in a fowl pox virus recombinant confers protection in chickens. J Viral 64: 1441-1450, 1990 
  31. Thacker EL, Fulton JE, Hunt HD: In vitro analysis of a primary, major histocompatibility complex (MHC)-restricted, cytotoxic T-Iymphocyte response to avian leukosis virus (ALV), using target cells expressing MHC class I cDNA inserted into a recombinant ALV vector. J Virol 69: 6439-6444, 1995 
  32. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, FeIgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745 -1749, 1993 
  33. Wu YT, Peng DX, Liu XF, Liu WZ, Zhang RK: A recombinant fowl pox virus expressing the fusion protein of Newcastle disease virus strain F48E8 and its protective efficacy. Sheng Wu Gong Cheng Xue Baa 16: 591-594, 2000 
  34. Yamanouchi K, Barrett T, Kai C: New approaches to the development of virus vaccines for veterinary use. Rev Sci Tech 17(3): 641-653, 1998 
  35. Zeng J, Fournier P, Schirrmacher V: High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules. Int J Oneal 25(2): 293-302, 2004 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • 원문 PDF 정보가 존재하지 않습니다.

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일